Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 543

1.

A neural mechanism of cue-outcome expectancy generated by the interaction between orbitofrontal cortex and amygdala.

Takei K, Fujita K, Kashimori Y.

Chem Senses. 2019 Oct 10. pii: bjz066. doi: 10.1093/chemse/bjz066. [Epub ahead of print]

PMID:
31599930
2.

Toward Flexible Surface-Enhanced Raman Scattering (SERS) Sensors for Point-of-Care Diagnostics.

Xu K, Zhou R, Takei K, Hong M.

Adv Sci (Weinh). 2019 Jul 2;6(16):1900925. doi: 10.1002/advs.201900925. eCollection 2019 Aug 21. Review.

3.

Marchiafava-Bignami disease with haemophagocytic lymphohistiocytosis as a postoperative complication of cardiac surgery.

Takei K, Motoyoshi N, Sakamoto K, Kitamoto T.

BMJ Case Rep. 2019 Aug 26;12(8). pii: e230368. doi: 10.1136/bcr-2019-230368.

PMID:
31451466
4.

Major patterns of plantar flexion resistive torque during the gait cycle in healthy young adults wearing ankle foot orthoses with a plantar flexion stop: a pilot study.

Fujimoto M, Suzuki S, Kuki H, Masuda M, Takei K, Yamamoto M.

J Phys Ther Sci. 2019 Jul;31(7):504-507. doi: 10.1589/jpts.31.504. Epub 2019 Jul 2.

5.

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Hachisu Y, Murata K, Takei K, Tsuchiya T, Tsurumaki H, Koga Y, Horie T, Takise A, Hisada T.

Medicina (Kaunas). 2019 May 13;55(5). pii: E132. doi: 10.3390/medicina55050132.

6.

ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration.

Hirose T, Cabrera-Socorro A, Chitayat D, Lemonnier T, Féraud O, Cifuentes-Diaz C, Gervasi N, Mombereau C, Ghosh T, Stoica L, Bacha JDA, Yamada H, Lauterbach MA, Guillon M, Kaneko K, Norris JW, Siriwardena K, Blasér S, Teillon J, Mendoza-Londono R, Russeau M, Hadoux J, Ito S, Corvol P, Matheus MG, Holden KR, Takei K, Emiliani V, Bennaceur-Griscelli A, Schwartz CE, Nguyen G, Groszer M.

J Clin Invest. 2019 Apr 15;129(5):2145-2162. doi: 10.1172/JCI79990. eCollection 2019 Apr 15.

7.

Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis.

Palumbo JM, Hubble J, Apple S, Takei K, Tsuda K, Liu S, Zhang J, Agnese W.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):421-431. doi: 10.1080/21678421.2019.1599955. Epub 2019 Apr 13.

PMID:
30982356
8.

5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase.

Narimatsu T, Kambara T, Abe H, Uematsu T, Tokura Y, Suzuki I, Sakamoto K, Takei K, Nishihara D, Nakamura G, Kokubun H, Yuki H, Betsunoh H, Kamai T.

Oncol Lett. 2019 May;17(5):4429-4436. doi: 10.3892/ol.2019.10086. Epub 2019 Feb 28.

9.

Graphene and Carbon Nanotube Heterojunction Transistors with Individual Gate Control.

Shiomi M, Mochizuki Y, Imakita Y, Arie T, Akita S, Takei K.

ACS Nano. 2019 Apr 23;13(4):4771-4777. doi: 10.1021/acsnano.9b01395. Epub 2019 Apr 4.

PMID:
30933474
10.

Flexible Electronics toward Wearable Sensing.

Gao W, Ota H, Kiriya D, Takei K, Javey A.

Acc Chem Res. 2019 Mar 19;52(3):523-533. doi: 10.1021/acs.accounts.8b00500. Epub 2019 Feb 15.

PMID:
30767497
11.

Response to Galán-Puchades and Fuentes.

Hamada K, Takemoto K, Takei K, Yamasaki Y, Fujiwara Y.

Am J Gastroenterol. 2019 Feb;114(2):357. doi: 10.14309/ajg.0000000000000118. No abstract available.

PMID:
30652984
12.

Phosphorylation of cortactin by cyclin-dependent kinase 5 modulates actin bundling by the dynamin 1-cortactin ring-like complex and formation of filopodia and lamellipodia in NG108-15 glioma-derived cells.

Abe T, La TM, Miyagaki Y, Oya E, Wei FY, Sumida K, Fujise K, Takeda T, Tomizawa K, Takei K, Yamada H.

Int J Oncol. 2019 Feb;54(2):550-558. doi: 10.3892/ijo.2018.4663. Epub 2018 Dec 11.

13.

Establishment of a Healthcare System for Patients With Adult Congenital Heart Disease in Collaboration With Children's Hospital - The Nagano Model.

Motoki H, Yasukochi S, Takigiku K, Takei K, Okamura T, Kimura K, Minamisawa M, Okada A, Saigusa T, Ebisawa S, Seto T, Shoda M, Okada K, Kuwahara K.

Circ J. 2019 Jan 25;83(2):424-431. doi: 10.1253/circj.CJ-18-0705. Epub 2018 Dec 20.

14.

LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice.

Ito S, Nagoshi N, Tsuji O, Shibata S, Shinozaki M, Kawabata S, Kojima K, Yasutake K, Hirokawa T, Matsumoto M, Takei K, Nakamura M, Okano H.

eNeuro. 2018 Dec 14;5(5). pii: ENEURO.0303-18.2018. doi: 10.1523/ENEURO.0303-18.2018. eCollection 2018 Sep-Oct.

15.

Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.

Kobayashi M, Uematsu T, Tokura Y, Takei K, Sakamoto K, Narimatsu T, Nukui A, Kamai T.

Int Braz J Urol. 2019 Jan-Feb;45(1):169-178. doi: 10.1590/S1677-5538.IBJU.2018.0271.

16.

All-Solution-Based Heterogeneous Material Formation for p-n Junction Diodes.

Yamamoto D, Shiomi M, Arie T, Akita S, Takei K.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):1021-1025. doi: 10.1021/acsami.8b15900. Epub 2018 Dec 17.

PMID:
30516962
17.

Prepulse inhibition in Drosophila melanogaster larvae.

Matsumoto Y, Shimizu K, Arahata K, Suzuki M, Shimizu A, Takei K, Yamauchi J, Hakeda-Suzuki S, Suzuki T, Morimoto T.

Biol Open. 2018 Sep 27;7(9). pii: bio034710. doi: 10.1242/bio.034710.

18.
19.

The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.

Kawakami Y, Saito Y, Nakagawa R, Kurihara Y, Takei K.

Neurosci Lett. 2018 Sep 14;683:61-68. doi: 10.1016/j.neulet.2018.06.045. Epub 2018 Jun 25.

PMID:
29953923
20.

Implication of Aortic Root Dilation and Stiffening in Patients with Tetralogy of Fallot.

Takei K, Murakami T, Takeda A.

Pediatr Cardiol. 2018 Oct;39(7):1462-1467. doi: 10.1007/s00246-018-1917-5. Epub 2018 Jun 6.

PMID:
29876583
21.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

22.

Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα.

Yamamoto Y, Takei K, Arulmozhiraja S, Sladek V, Matsuo N, Han SI, Matsuzaka T, Sekiya M, Tokiwa T, Shoji M, Shigeta Y, Nakagawa Y, Tokiwa H, Shimano H.

Biochem Biophys Res Commun. 2018 May 5;499(2):239-245. doi: 10.1016/j.bbrc.2018.03.135. Epub 2018 Mar 22.

PMID:
29567478
23.

Photoresponse of graphene field-effect-transistor with n-type Si depletion layer gate.

Kobayashi S, Anno Y, Takei K, Arie T, Akita S.

Sci Rep. 2018 Mar 19;8(1):4811. doi: 10.1038/s41598-018-22974-7.

24.

Taenia saginata Infection Diagnosed Based on the Number of Uterine Branches Observed During Capsule Endoscopy.

Hamada K, Takemoto K, Takei K, Yamasaki Y, Fujiwara Y.

Am J Gastroenterol. 2018 Mar;113(3):327. doi: 10.1038/ajg.2017.444. No abstract available.

PMID:
29535435
25.

Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation.

Takahashi K, Takeuchi H, Kurihara Y, Doi H, Kunii M, Tanaka K, Nakamura H, Fukai R, Tomita-Katsumoto A, Tada M, Higashiyama Y, Joki H, Koyano S, Takei K, Tanaka F.

J Neuroinflammation. 2018 Feb 17;15(1):46. doi: 10.1186/s12974-018-1084-x.

26.

A soft lithographic approach to fabricate InAs nanowire field-effect transistors.

Lee SH, Shin SH, Madsen M, Takei K, Nah J, Lee MH.

Sci Rep. 2018 Feb 16;8(1):3204. doi: 10.1038/s41598-018-21420-y.

27.

The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.

Kawakami Y, Kurihara Y, Saito Y, Fujita Y, Yamashita T, Takei K.

J Neurosci. 2018 Mar 7;38(10):2589-2604. doi: 10.1523/JNEUROSCI.0953-17.2018. Epub 2018 Feb 9.

28.

MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.

Maruyama T, Nishihara K, Umikawa M, Arasaki A, Nakasone T, Nimura F, Matayoshi A, Takei K, Nakachi S, Kariya KI, Yoshimi N.

Oncol Lett. 2018 Feb;15(2):2349-2363. doi: 10.3892/ol.2017.7562. Epub 2017 Dec 8.

29.

Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.

Federige MAF, Romaldini JH, Miklos ABPP, Koike MK, Takei K, Portes ES.

Arch Endocrinol Metab. 2017 Dec;61(6):600-607. doi: 10.1590/2359-3997000000309.

30.

Evolving affinity between Coulombic reversibility and hysteretic phase transformations in nano-structured silicon-based lithium-ion batteries.

Ogata K, Jeon S, Ko DS, Jung IS, Kim JH, Ito K, Kubo Y, Takei K, Saito S, Cho YH, Park H, Jang J, Kim HG, Kim JH, Kim YS, Choi W, Koh M, Uosaki K, Doo SG, Hwang Y, Han S.

Nat Commun. 2018 Feb 2;9(1):479. doi: 10.1038/s41467-018-02824-w.

31.

Dynamic clustering of dynamin-amphiphysin helices regulates membrane constriction and fission coupled with GTP hydrolysis.

Takeda T, Kozai T, Yang H, Ishikuro D, Seyama K, Kumagai Y, Abe T, Yamada H, Uchihashi T, Ando T, Takei K.

Elife. 2018 Jan 23;7. pii: e30246. doi: 10.7554/eLife.30246.

32.

Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer.

Kamai T, Tokura Y, Uematsu T, Sakamoto K, Suzuki I, Takei K, Narimatsu T, Kambara T, Yuki H, Betsunoh H, Abe H, Fukabori Y, Yashi M, Yoshida KI.

Open Heart. 2018 Jan 3;5(1):e000666. doi: 10.1136/openhrt-2017-000666. eCollection 2018.

33.

An Acute Case of Granulomatous Amoebic Encephalitis-Balamuthia mandrillaris Infection.

Takei K, Toyoshima M, Nakamura M, Sato M, Shimizu H, Inoue C, Shimizu Y, Yagita K.

Intern Med. 2018 May 1;57(9):1313-1316. doi: 10.2169/internalmedicine.0011-17. Epub 2018 Jan 11.

34.

Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.

Abe H, Takei K, Uematsu T, Tokura Y, Suzuki I, Sakamoto K, Nishihara D, Yamaguchi Y, Mizuno T, Nukui A, Kobayashi M, Kamai T.

Int J Clin Oncol. 2018 Apr;23(2):338-346. doi: 10.1007/s10147-017-1207-x. Epub 2017 Nov 2.

PMID:
29098519
35.

A Japanese Case of Esophageal Lichen Planus that Was Successfully Treated with Systemic Corticosteroids.

Sato Y, Takenaka R, Matsumi A, Takei K, Okanoue S, Yasutomi E, Kawai D, Takemoto K, Tsugeno H, Miyake T, Fujiki S.

Intern Med. 2018 Jan 1;57(1):25-29. doi: 10.2169/internalmedicine.8668-16. Epub 2017 Oct 11.

36.

Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS.

Hirokawa T, Zou Y, Kurihara Y, Jiang Z, Sakakibara Y, Ito H, Funakoshi K, Kawahara N, Goshima Y, Strittmatter SM, Takei K.

Sci Rep. 2017 Sep 21;7(1):12119. doi: 10.1038/s41598-017-12449-6.

37.

Resonance Control of a Graphene Drum Resonator in a Nonlinear Regime by a Standing Wave of Light.

Inoue T, Anno Y, Imakita Y, Takei K, Arie T, Akita S.

ACS Omega. 2017 Sep 14;2(9):5792-5797. doi: 10.1021/acsomega.7b00699. eCollection 2017 Sep 30.

38.

LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice.

Takase H, Kurihara Y, Yokoyama TA, Kawahara N, Takei K.

PLoS One. 2017 Sep 7;12(9):e0184258. doi: 10.1371/journal.pone.0184258. eCollection 2017.

39.

Preoperative Pulmonary Function Tests Predict Aspiration Pneumonia After Gastric Endoscopic Submucosal Dissection.

Matsumi A, Takenaka R, Ando C, Sato Y, Takei K, Yasutomi E, Okanoue S, Oka S, Kawai D, Kataoka J, Takemoto K, Tsugeno H, Fujiki S, Kawahara Y.

Dig Dis Sci. 2017 Nov;62(11):3084-3090. doi: 10.1007/s10620-017-4750-4. Epub 2017 Sep 6.

PMID:
28879570
40.

Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis.

Takei K, Tsuda K, Takahashi F, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):64-70. doi: 10.1080/21678421.2017.1365372.

PMID:
28872916
41.

Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis.

Takahashi F, Takei K, Tsuda K, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):32-39. doi: 10.1080/21678421.2017.1361442.

PMID:
28872914
42.

Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Takei K, Takahashi F, Liu S, Tsuda K, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):49-54. doi: 10.1080/21678421.2017.1361443.

PMID:
28872913
43.

An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe.

Takei K, Tsuda K, Takahashi F, Hirai M, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):88-97. doi: 10.1080/21678421.2017.1361445. Review.

PMID:
28872912
44.

Pharmacokinetic profile of edaravone: a comparison between Japanese and Caucasian populations.

Nakamaru Y, Kinoshita S, Kawaguchi A, Takei K, Palumbo J, Suzuki M.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):80-87. doi: 10.1080/21678421.2017.1353100.

PMID:
28872908
45.

Edaravone and its clinical development for amyotrophic lateral sclerosis.

Takei K, Watanabe K, Yuki S, Akimoto M, Sakata T, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):5-10. doi: 10.1080/21678421.2017.1353101. Review.

PMID:
28872907
46.

Pfannenstiel laparoendoscopic reduced-port bilateral radical nephrectomy for a patient with renal cell carcinoma undergoing hemodialysis.

Nomura T, Yamasaki M, Takei K, Sato F, Terachi T, Mimata H.

Asian J Endosc Surg. 2018 May;11(2):177-181. doi: 10.1111/ases.12417. Epub 2017 Aug 30.

PMID:
28856871
47.

[Diagnostic Impact of 3D-CT with Retrograde Pyelography for Ureteropelvic Junction Obstruction : A Case Report].

Takei K, Abe H, Nishihara D, Mizuno T, Tokura Y, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunou H, Yashi M, Fukabori Y, Kamai T, Inamura K, Shioyama Y, Kaji Y.

Hinyokika Kiyo. 2017 Jul;63(7):267-270. doi: 10.14989/ActaUrolJap_63_7_267. Japanese.

48.

Wearable, Flexible, and Multifunctional Healthcare Device with an ISFET Chemical Sensor for Simultaneous Sweat pH and Skin Temperature Monitoring.

Nakata S, Arie T, Akita S, Takei K.

ACS Sens. 2017 Mar 24;2(3):443-448. doi: 10.1021/acssensors.7b00047. Epub 2017 Mar 13.

PMID:
28723207
49.

Efficient Skin Temperature Sensor and Stable Gel-Less Sticky ECG Sensor for a Wearable Flexible Healthcare Patch.

Yamamoto Y, Yamamoto D, Takada M, Naito H, Arie T, Akita S, Takei K.

Adv Healthc Mater. 2017 Sep;6(17). doi: 10.1002/adhm.201700495. Epub 2017 Jun 29.

PMID:
28661047
50.

Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.

Yashi M, Nukui A, Tokura Y, Takei K, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunoh H, Abe H, Fukabori Y, Nakazato Y, Kaji Y, Kamai T.

BMC Urol. 2017 Jun 23;17(1):47. doi: 10.1186/s12894-017-0238-y.

Supplemental Content

Support Center